Cases and resources in vascular techniques

This prospective study assessed the link between Ex-TcpO2 results and postoperative outcomes in 82 patients with intermittent claudication. Clinical improvement and patency rates correlated with Ex-TcpO2 findings, highlighting its potential as a diagnostic tool, particularly for atypical or uncertain arterial claudication.

At PVI 2024, Dr. Bruno Migliara explores the challenges of treating below-the-knee disease and demonstrates how the Oscar device (4F & 6F) simplifies crossing and preparation in even the most complex BTK and BTA lesions. With real-world clinical examples, see how - thanks to its support catheter, dilator, and length-adjustable PTA balloon - Oscar tackles CTOs, calcification, small-vessel disease, and more. Watch now to see Oscar in action!

In this PVI 2024 interview, Dr. Mauro Gargiulo explores the growing role of CO2 angiography in EVAR. This technique reduces contrast media use, lowers the risk of acute kidney injury, and enhances procedural precision by improving endoleak detection and optimizing endograft placement. Already tested in FEVAR and BEVAR, CO2 angiography is paving the way for safer, more effective aortic interventions.

This retrospective study investigated the impact of atherosclerosis in multiple arterial beds on mortality and morbidity in patients undergoing elective EVAR. The findings showed that patients with polyvascular disease had a higher risk of peri-operative MACE and death. The risk increased with the number of arterial beds affected, suggesting that these patients should be considered high-risk and managed accordingly.

A 69-year-old male with a complex vascular history, including prior stents and endarterectomy, presents with worsening left leg ischemia (Rutherford class IV).

At PVI 2024, Dr. Tara Mastracci emphasizes the importance of managing blood pressure and using remote monitoring in type B aortic dissection. She explains how proper hypertension control can improve outcomes and change the disease's progression, especially in acute cases.

This study compares the perioperative and long-term outcomes of open versus endovascular revascularization for lower limb ischemia involving the common femoral artery (CFA). A particular focus is placed on reintervention rates and MALES-free survival (Major Adverse Limb Events).

Join Stéphan Haulon in this PVI 2024 session as he takes us through the FEVAR Revolution. Discover how new technologies like 3D imaging, steerable sheaths, and dedicated bridging stents are transforming complex aortic repair procedures. Watch as he introduces the BeFlared device—an exciting new tool that’s changing the game in FEVAR. Get an inside look at how this technology is improving outcomes and making procedures safer and more efficient. Don’t miss out on this deep dive into the future of FEVAR!

In this PVI 2024 interview, Dr. Sarah Thomis discusses the latest advancements in treating superficial venous disease.

At PVI 2024, a session highlighted how social networks can serve as powerful educational tools in vascular intervention while addressing potential challenges. Learn to promote your practice, evaluate social media content, and create impactful, evidence-based posts. Ethical concerns and data misuse were also explored. Watch the replay to enhance your social media skills for vascular practice!